{
  "https://www.natera.com/oncology": "d23dcab14cf3f37d9638a51bcf069cae7261a646ece7998d3ce0b7889b809ae6",
  "https://www.natera.com/company/news": "4d284b586f50c10b71ad57c222a6e2ea4835785a72a1fac6733a25735bea6db0",
  "https://guardanthealth.com/products/tests-for-cancer-screening": "33e88c47f94e40f36d797a8324667689312e4cf4b54726c8eb3c5bb804338880",
  "https://guardanthealth.com/products/tests-for-patients-with-early-and-advanced-stage-cancer": "fa759628ef01a7255b374a3d34eb012998ab1d3724b79b464fcccf4d4e791c5a",
  "https://guardanthealth.com/newsroom/press-releases": "bb38d055607f495846158d82bd42c454994ca136132e404fc4d1c85f67ca3e67",
  "https://www.foundationmedicine.com/genomic-testing/foundation-one-cdx": "8a79a20216e5f86be0622adc5a1feda328e3b0eb4076b1d6302c69a2cfb9598d",
  "https://www.foundationmedicine.com/test/foundationone-liquid-cdx": "8104f26789cd25ee1fc03bedcec35376321ee9d50e54a2ea0480802b56f79100",
  "https://www.foundationmedicine.com/press-releases": "4b0350046a65ae5dc6e47e7b8e5b40d8be5bbd77476a795836a7e361d7cdee30",
  "https://www.tempus.com/oncology/genomic-profiling": "65afe2256ef591b777af6e9e184bc99ec2c26409c4a941c0f1431a5075bed143",
  "https://www.tempus.com/news": "ffe9c7331ba96edfea179d8b83200e9511c6159dcee17689bc2e354087e3fa20",
  "https://www.carislifesciences.com/products-and-services/molecular-profiling": "42d603b72301731bcaa0781adeffbc13f7df4e7ca4fd22fb01166e25a706a384",
  "https://www.carislifesciences.com/news-and-events/news": "18e22f2dd4c2633c229055b91f41291a74dbe9e9f6af536bb1a208c2ae27f577",
  "https://www.grail.com/galleri": "881bbd1a139b982232360c8dba737ef21771097e49b9ff380d2c02d10e6108bc",
  "https://www.grail.com/press-releases": "d828a69e95cc23aa5b1a97b76dc06bfb1997fb9ce1385ebdd7a86043dd221e1d",
  "https://www.exactsciences.com/newsroom": "ee62f009ab9e6e4a140dfcd140aabf93a9c60f0c0e39bbbf991069f162588d41",
  "https://www.labcorp.com/newsroom": "7dc87bfee5cc369737f08322eb9ccc21986cccc00325e24965d114b68076f08b",
  "https://neogenomics.com/newsroom": "0ade756bcbd67705168432573e38163f59a43e6d2798cd02edb2266ec04c4c62",
  "https://www.personalis.com/news": "10efbba75a9970952f5b9613cb1e22650246631179608b846e62b6c18abc1d82",
  "https://myriad.com/news-events/news": "8ecdce93d667228f841081a42871dd751e1c644c72190255af7aeea4219a3a6a",
  "https://www.invitae.com/en/press": "7dc87bfee5cc369737f08322eb9ccc21986cccc00325e24965d114b68076f08b",
  "https://www.freenome.com/news": "da726d99d28d02281ed03125ef252f218a7bd4bf15cb8f1eddb3663bea69d8fc",
  "https://billiontoone.com/news": "4f9a5ef166dd65592f193ff51464cc7cbbe29ac32123db30745d1b21cd36bd01",
  "https://www.resolutionbio.com/news": "3f9bc2cdb35bfecc0843780a9cc6a27ff205ee2cc93eecf070b720795159cce5",
  "https://www.brbiotech.com/news": "cd6c552d454ec0a0cc201ec47834bba196b94685669eb11c34f42a54a653906c",
  "https://www.helio.health/news": "705d83c126b3c66d22b7052ead3c59083f786240d681db7ac234a10e98988f12",
  "https://newsroom.questdiagnostics.com/press-releases": "cc54a0cdbf02675a9df4336b7aae983228ac579cc3225b34ea2494eb5203eb76",
  "https://investors.adaptivebiotech.com/rss/news-releases.xml": "6275535b3d8844045553110de7e1493b290ea74939e1d836d221263d1542303f",
  "https://investor.veracyte.com/rss/news-releases.xml": "92b8c311459ef4ec264d502b58f9cc335debf23ff3479f6f3e7ebed03e365aed"
}